Influence
January 10, 2025

Asthma Among Children With Primary Ciliary Dyskinesia

Arthur H. Owora, PhD

Published in the journal JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Arthur H. Owora, PhD, MPH

This case-control study investigated whether asthma should be routinely considered a comorbidity in children with primary ciliary dyskinesia (PCD), a condition caused by mutations in genes affecting motile cilia. Researchers analyzed data from two large electronic health record databases—Indiana Network for Patient Care Research (INPCR) and TriNetX—focusing on children 18 years or younger with both bronchiectasis and situs inversus totalis (B-SIT), a combination highly indicative of PCD. In INPCR, all 9 children with B-SIT had asthma, compared to 1 of 27 controls (P < .001). In TriNetX, 84 of 115 children with B-SIT had asthma, compared to 12 of 115 controls (P = 2.2 × 10⁻¹⁶), with an adjusted odds ratio of 22.3. The study concludes that asthma is significantly more common in children with likely PCD. This supports prior research suggesting antigen stasis in PCD may contribute to asthma-like inflammation. The findings suggest children with PCD should be evaluated for asthma, and some children with asthma may warrant evaluation for underlying PCD features.

Author Affiliations

Joe Zein 1Arthur Owora 2 3Hyun Jo Kim 4Nadzeya Marozkina 2Benjamin Gaston 2
Affiliations

Affiliations

1Department of Medicine, Division of Pulmonary and Sleep Medicine, Mayo Clinic, Scottsdale, Arizona.

2Department of Pediatrics and Riley Hospital for Children, Indiana University School of Medicine, Indianapolis.

3Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana.

4Department of Bioinformatics and Systems Biology, Case Western Reserve University, Cleveland, Ohio.

Related News

Dr. Peter J. Embi

Regenstrief’s legacy with the National Library of Medicine continues

Peter J. Embí, M.D., M.S., former president and CEO of the Regenstrief Institute, has been appointed director of the

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief

LOINC® version 2.83 enhances global health data exchange through new terminology and implementation improvements

Release expands terminology for drug and toxicology testing, microbiology, public health reporting and allergy information Regenstrief Institute has released

Matt Bair, MD

Regenstrief researcher appointed deputy chief of research and development service at Richard L. Roudebush VA Medical Center

Matthew Bair, M.D., M.S., a research scientist at the Regenstrief Institute and professor of medicine at the Indiana University